REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 67 filers reported holding REDHILL BIOPHARMA LTD in Q1 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,170,000 | -46.1% | 1,045,023 | +21.3% | 0.01% | -22.2% |
Q1 2022 | $2,172,000 | +2368.2% | 861,798 | +4404.5% | 0.01% | – |
Q3 2021 | $88,000 | -98.4% | 19,132 | -97.6% | 0.00% | -100.0% |
Q2 2021 | $5,418,000 | -4.6% | 787,469 | +1.5% | 0.01% | -9.1% |
Q1 2021 | $5,678,000 | +321.5% | 775,698 | +365.2% | 0.01% | +175.0% |
Q4 2020 | $1,347,000 | +7.2% | 166,749 | +35.7% | 0.00% | -42.9% |
Q3 2020 | $1,256,000 | +28.3% | 122,860 | -15.9% | 0.01% | -36.4% |
Q2 2020 | $979,000 | +124.5% | 146,162 | +52.0% | 0.01% | 0.0% |
Q1 2020 | $436,000 | +23.2% | 96,151 | +64.7% | 0.01% | +22.2% |
Q4 2019 | $354,000 | -9.9% | 58,373 | +4.5% | 0.01% | 0.0% |
Q3 2019 | $393,000 | +1.0% | 55,886 | -6.6% | 0.01% | -10.0% |
Q2 2019 | $389,000 | -29.0% | 59,820 | -9.3% | 0.01% | -37.5% |
Q1 2019 | $548,000 | +62.6% | 65,918 | +8.5% | 0.02% | +14.3% |
Q4 2018 | $337,000 | -22.4% | 60,741 | +23.7% | 0.01% | +7.7% |
Q3 2018 | $434,000 | -54.8% | 49,121 | -56.4% | 0.01% | -62.9% |
Q2 2018 | $961,000 | +80.0% | 112,648 | +8.6% | 0.04% | +29.6% |
Q1 2018 | $534,000 | +258.4% | 103,754 | +257.3% | 0.03% | +125.0% |
Q4 2017 | $149,000 | – | 29,040 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 300 | $2,175 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |